|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 37.88 USD | -4.27% |
|
-11.23% | -23.78% |
| 09-17 | Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger | MT |
| 08-03 | Supernus Pharmaceuticals, Inc. Revises Earnings Guidance for the Full Year 2026 | CI |
Stock exchange
Nasdaq
SUPN 37.88 $
-4.27%
54.61M
$
Quotes 5-day view: Supernus Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 2026-10-12 | 2026-10-13 | 2026-10-14 | 2026-10-15 | 2026-10-16 | |
|---|---|---|---|---|---|
| Last | US$42.81 | US$42.01 | US$40.18 | US$39.57 | US$37.88 |
| Volume | 914,563 | 1,196,915 | 906,715 | 1,013,118 | 1,441,632 |
| Change | +0.33% | -1.87% | -4.36% | -1.52% | -4.27% |
| Opening | US$42.67 | US$42.94 | US$41.93 | US$40.21 | US$39.49 |
| High | US$43.20 | US$43.29 | US$43.26 | US$41.31 | US$39.50 |
| Low | US$41.90 | US$41.71 | US$39.97 | US$39.36 | US$37.54 |
Performance
| 1 day | -4.27% | ||
| 1 week | -11.23% | ||
| Current month | -11.99% | ||
| 1 month | -8.46% | ||
| 3 months | -21.43% | ||
| 6 months | -23.04% | ||
| Current year | -23.78% | ||
| 1 year | -23.87% | ||
| 3 years | +46.71% | ||
| 5 years | +19.65% | ||
| 10 years | +82.03% |
Volumes
marketsDaily volume
1,441,632
Estimated daily volume
1,441,632
Avg. Volume 20 sessions
780,494
Daily volume ratio
1.85
Avg. Volume 20 sessions USD
29,565,112.72
Record volume 1
11,208,680
Record volume 2
6,737,648
Record volume 3
6,644,855
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
2,201,851,252
Net sales (USD)
718,952,000
Number of employees
778
Sales / Employee (USD)
924,103
Free-Float
95.68%
Free-Float capitalization (USD)
2,110,201,956
Average Daily Capital Traded
1.34%
Indicators
Moving average 5 days
40.49
Moving average 20 days
42.6
Moving average 50 days
44.01
Moving average 100 days
45
Price spread / (MMA5)
+6.89%
Price spread / (MMA20)
+12.47%
Price spread / (MMA50)
+16.19%
Price spread / (MMA100)
+18.79%
RSI 9 days
26.47
RSI 14 days
32.33
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.27% | -11.23% | -23.87% | +46.71% | 2.2B | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,120B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 616B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 504B | |
| -0.13% | +5.98% | +32.91% | +50.39% | 367B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 360B | |
| -0.95% | +4.70% | +19.51% | +43.00% | 288B | |
| -1.98% | +3.73% | -0.86% | +13.43% | 258B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 234B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 194B | |
| Average | -0.59% | +2.13% | +29.26% | +60.16% | 394.31B | |
| Weighted average by Cap. | +0.13% | +3.82% | +39.14% | +71.42% |
Historical Quotes: Supernus Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
bb08c7e2e3ef454.zuhrR50TciQTRsJzMZhyVnkdGiWM_t_luOnxxmzJu_k._tsaIth3EWtmDogYR9E7Jh8wexy0tu6w8o6W8wnxwr2ttw4r71QlbkkrrQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 37.88 | 86,645 | 1,087,153 |
| 15:59:59 | 37.88 | 100 | 1,000,508 |
| 15:59:59 | 37.89 | 100 | 1,000,408 |
| 15:59:59 | 37.89 | 200 | 1,000,308 |
| 15:59:59 | 37.86 | 130 | 1,000,108 |
| 15:59:56 | 37.87 | 100 | 999,978 |
| 15:59:55 | 37.84 | 100 | 999,878 |
| 15:59:55 | 37.88 | 100 | 999,778 |
| 15:59:55 | 37.88 | 100 | 999,678 |
| 15:59:55 | 37.88 | 100 | 999,578 |
Price Extremes
| 1 week | 37.54 |  | 43.29 |
| 1 month | 37.54 | | 44.93 |
| Current year | 37.54 | | 59.68 |
| 1 year | 37.54 | | 59.68 |
| 3 years | 21.99 | | 59.68 |
| 5 years | 21.99 | | 59.68 |
| 10 years | 13.12 | | 61.25 |
Monthly variations
Annual variations
| 2026 | -23.78% | ||
| 2025 | +37.44% | ||
| 2024 | +24.95% | ||
| 2023 | -18.87% | ||
| 2022 | +22.33% | ||
| 2021 | +15.90% | ||
| 2020 | +6.07% | ||
| 2019 | -28.60% | ||
| 2018 | -16.64% | ||
| 2017 | +57.82% | ||
| 2016 | +87.87% | ||
| 2015 | +61.93% | ||
| 2014 | +10.08% | ||
| 2013 | +5.16% | ||
| 2012 | +33.52% |
- Stock Market
- Stocks
- SUPN Stock
- Quotes Supernus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
